3 Hot Small Cap Stocks You Should Know

By James Yeo //
August 11, 2020
2020 has been a tumultuous year thus far. COVID-19 cases have been rising everyday and deaths from COVID-19 saw no signs of slowing down. Tourism came to a halt, and leisure places such as pubs, karaoke, movie theatres, etc. were majorly affected. As a result, economies plunged significantly, and the world superpowers are facing with one of the worst recessions in human history. There are some industries however, faring better than others. Companies in these industries fared better in terms of demand and translated to better stock returns. We have endeavoured and found 3 smallcap stocks listed on SGX with the highest year-to-date returns that you should take note of.

#1 Medtechs International Corporation

Medtechs is a manufacturer of medical consumable ranging from gowns, masks to PPE suits for the pandemic. It has d a strong presence in the United States, Europe and Asia Pacific. The Group has offices and facilities spanning across Asia – in Singapore, Taiwan, the Philippines, China, and Cambodia. As of the latest annual report, Medtech’s revenue increased by 1% to USD 69 million. Its net profit increased substantially by 27.6% to USD 1.2 million. Free cash flow came in at a strong level of USD 2.4 million. Cash balance of the company stands at a healthy level of USD 3.1 million. Medtechs has one of the highest YTD returns out of all SGX stocks. It has an outstandingly high YTD return of 2400% with share prices trading at $0.04 on 2nd January 2020 to $0.97 on 7th Aug 2020. Medtechs last closed at $0.97, which values it at a trailing P/E ratio of 340x and has not declared any dividends for the year of 2019.

#2 IPS Securex Holdings Limited

IPS is one of Singapore’s leading providers of security products and integrated security solutions. It has businesses with commercial entities, government bodies and agencies in the Asia-Pacific. The Group carries over 100 types of security products with distribution rights for certain products spanning the Asia-Pacific. As of the latest quarterly report, IPS’s revenue increased admirably by 47% to $3.2 million. Its net profit turned positive to $148,735. Free cash flow was at a negative value of $0.37 million due to a large purchase of inventories. Cash balance of the company is maintained at a good level of $3.5 million. IPS Securex has a YTD return of 323% with share prices trading at $0.038 on 3rd January 2020 to $0.123 on 7 August 2020. IPS Securex has recorded a negative profit for the year 2019, thus no tangible P/E could be calculated. No dividends were declared for 2019.

#3 Hyphens Pharma International Limited

Hyphens Pharma markets and sells a range of specialty pharmaceutical products such as health products and dermatological products. The businesses are conducted through exclusive distributorship or licensing and supply agreements. It has presence in Singapore, Indonesia, Malaysia, Philippines, Vietnam, Hongkong, etc. As of the latest quarterly report, Hyphens’s revenue increased by 16.4% to $ 31.4 million. Its net profit increased significantly by 48.6% to $2.1 million. Free cash flow came in at $1.99 million. Cash balance of the company is kept a sustainable level of $27.8 million. On top of its good financials, Hyphens Pharma has received a UK patent for its Ceradan Advanced product and is expanding its portfolio of brands with hair-loss products. Hyphens Pharma last closed at $0.56, which values it at a P/E ratio of 23.28 and dividend yield of 1.78%.
“Want to stay in the loop for top ideas and exclusive content, subscribe to our FREE newsletter here.”
 Previous
Next

About the author James Yeo

Leave a Comment

Check Out Our Latest Articles

Oversea-Chinese Banking Corp – Steady Execution

Excerpts from UOBKayHian report Oversea-Chinese Banking Corporation (SGX: O39) Oversea-Chinese Banking Corp (OCBC) delivered a near-record net profit of S$1,944m in 2Q24 (+14% yoy), supported by strong net trading income and lower credit costs. NPL formation was benign at S$108m. Loan-loss coverage improved 24ppt yoy and 9ppt qoq to 156%, the highest among the local

Read More

Interest Rate Cut Effect: How REITs Can Outperform

For the past 2 years, the US Federal Reserve hiked interest rates to the present 5.25% to 5.5%, which is the highest since 2007. The sharp increases, coupled with high inflation led to lower DPU for most REITs due to higher financing costs. With impending interest rate cut by the FED, REIT investors could breathe

Read More

Mapletree Pan Asia Commercial Trust – Driving resilience

Excerpts from Maybank report Mapletree Pan Asia Commercial Trust (SGX: N2IU) Mapletree Pan Asia Commercial Trust (MPACT) 1Q25 DPU of SGD2.09cts fell 8.7% QoQ and -4.1% YoY, in line with our est. Forex headwinds and pockets of weakness in overseas markets offset growing contribution from Singapore assets. Reversion picked up in 1Q25 to +5.2% due to

Read More

3 Defensive REITs I Plan to Buy When the Market Crashes

The REIT sector have come under pressure this year and may face further downside when the US economy falls into a recession next year. We could see a more prolonged market correction this year similar to the correctio in the first week of August. When the market actually crashes in 2025 and 2026, it will

Read More